Management of Iron Deficiency with Normal Hemoglobin
Treatment Approach
- The British Society of Gastroenterology recommends continuing oral iron supplementation for at least 3 months after ferritin normalization to fully replenish iron stores, with a target ferritin of at least 50 ng/mL 1
- Ferrous sulfate 200-324 mg (65 mg elemental iron) three times daily remains the most effective and cost-efficient option for iron supplementation 1
- Treatment must continue for 3 months after hemoglobin and ferritin normalize to adequately replenish body iron stores 1
- The target ferritin should be at least 50 ng/mL before considering stopping therapy 1, 2
Monitoring Strategy
- Recheck ferritin and hemoglobin in 3 months to assess response 1
- Once ferritin normalizes (>50 ng/mL), continue iron for an additional 3 months, then monitor at 3-month intervals for the first year, then annually 1
- If ferritin or hemoglobin falls below normal during follow-up, resume oral iron supplementation 1
Important Clinical Context for Premenopausal Women
- All patients with confirmed iron deficiency should receive iron supplementation regardless of the underlying cause, according to the British Society of Gastroenterology guidelines 1
- Menstruating women commonly develop iron deficiency (5-10% prevalence) due to menstrual loss, pregnancy, and breastfeeding 1
- If dietary deficiency is excluded and iron supplementation fails to maintain normal levels, gastrointestinal evaluation should be considered 1
Common Pitfalls to Avoid
- Do not stop iron therapy prematurely when hemoglobin normalizes—ferritin must also normalize and stores must be replenished 1
- Avoid iron-fortified foods and supplemental vitamin C during the initial treatment phase if hemochromatosis is a consideration, though this is unlikely given the low ferritin 3
- Do not use ferritin alone to guide therapy—consider it alongside hemoglobin levels and clinical symptoms 4, 5